did not reach statistical significancep value = 0.510
There was a trend towards a greater increase in LDL cholesterol in the efavirenz arm (0.30 mmol/L [IQR -0.20,0.56]) compared with the other treatment regimens which had stable or slight decreases in LDL cholesterol (atazanavir/r 0.16 mmol/L [IQR -0.40,0.89]; zidovudine/abacavir -0.07 [IQR -0.4,0.5]) but this did not reach statistical significance (p value = 0.510).